微生物群
肠道微生物群
疾病
阿尔茨海默病
生物
医学
微生物学
生物信息学
内科学
作者
Yushi Dong,Xilin Wu,Yumeng Zhang,Adi Hu,Qian Zhou,Xiqing Yue,Zhenmin Liu,Mohan Li
出处
期刊:Foods
[Multidisciplinary Digital Publishing Institute]
日期:2025-04-27
卷期号:14 (9): 1531-1531
被引量:15
标识
DOI:10.3390/foods14091531
摘要
Alzheimer's disease (AD) has emerged as a global public health priority characterized by escalating prevalence and the limited efficacy of current therapeutic approaches. Although the pathological complexity of AD is well-recognized, its underlying etiology remains incompletely elucidated. Current research highlights a bidirectional gut-brain axis (GBA) interaction, wherein gut microbiome perturbations may impair intestinal barrier stability, influence immune responses, and blood-brain barrier permeability through microbial metabolite-mediated pathways, thereby contributing to AD pathophysiology. Notably, probiotics demonstrate therapeutic potential by restoring gut microbiome homeostasis, reinforcing intestinal barrier integrity, and mitigating neuroinflammatory responses via GBA. This review focuses on investigating the gut microbiome alterations in AD pathogenesis, the interaction of probiotics with GBA, and its significance in AD pathogenesis. By synthesizing current clinical evidence, this review aims to establish a scientific foundation for probiotic-based interventions as a novel therapeutic strategy in AD management.
科研通智能强力驱动
Strongly Powered by AbleSci AI